Weight loss drug, lorcaserin found to solve opiate abuse

A recent research has found out that a weight loss drug given by prescription has the potential to reduce the urge to use opiates (anti-anxiety drugs) including oxycodone.

Weight loss drug, lorcaserin found to solve opiate abuse

A recent research has found out that a weight loss drug given by prescription has the potential to reduce the urge to use opiates (anti-anxiety drugs) including oxycodone. The weight loss drug that could potentially solve opiate abuse is lorcaserin according to the Galveston’s University of Texas Medical Branch (UTMB). In preclinical studies by the […]

Lilly’s breast cancer drug abemaciclib meets objective in phase 3 trial

Lilly’s breast cancer drug, abemaciclib given in combination with fulvestrant has met its primary endpoint of progression-free survival (PFS) in a phase 3 breast cancer trial.

Lilly’s breast cancer drug abemaciclib meets objective in phase 3 trial

Indianapolis-based Lilly has reported that its breast cancer drug, abemaciclib, in combination with fulvestrant, has yielded positive results by meeting its primary endpoint, progression-free survival (PFS) in a phase 3 breast cancer trial. The combination of Lilly breast cancer drug abemaciclib with fulvestrant was proved to be more effective than the fulvestrant plus placebo combination […]

New oral blood thinner rivaroxaban from Bayer and Jannsen shown to cut recurrence of life-threatening blood clots

Check out results of the late-breaking blood thinner clinical trial of Rivaroxaban, Bayer & Janssen’s oral blood thinner for deep vein thrombosis treatment.

New oral blood thinner rivaroxaban from Bayer and Jannsen shown to cut recurrence of life-threatening blood clots

Bayer and Janssen Pharmaceuticals have revealed that their jointly developed oral blood thinner Xarelto (rivaroxaban) had considerably brought down the risk of recurring formation of life-threatening blood clots in the vein as per the findings of their late-breaking study. Rivaroxaban Blood Thinner Clinical Trial This, they demonstrated in a blood thinner clinical trial dubbed EINSTEIN CHOICE. […]

Astrazeneca ovarian cancer drug Lynparza shown to improve survival chances

Check out details of Astrazeneca Ovarian Cancer Drug, Lynparza which in a phase 3 trial has been demonstrated to have improved survival of patients treated with Lynparza Ovarian Cancer Tablets.

Astrazeneca ovarian cancer drug Lynparza shown to improve survival chances

Pharma giant AstraZeneca has reported that its ovarian cancer drug Lynparza (olaparib) as a maintenance therapy has considerably improved the survival chances of patients with germline BRCA-mutations (gBRCA) who had a relapse of the disease, who did not respond to platinum-based chemo. Phase 3 Trial of Astrazeneca Ovarian Cancer Drug Lynparza The observation of the […]

Amgen cholesterol injection Repatha reduces heart attack, stroke chances

Check out details of Amgen Cholesterol Injection phase 3 trial results which demonstrated that Repatha cholesterol injection with statin therapy reduce heart attack, stroke chances.

Amgen cholesterol injection Repatha reduces heart attack, stroke chances

Amgen cholesterol injection Repatha (evolocumab) has been demonstrated to have cut heart attack and stroke risk by 20% in a phase 3 cardiovascular outcomes study featuring 27,564 patients with heart diseases. Amgen Cholesterol Trial for Repatha Cholesterol Injection During the trial, it was proven that by maximum reduction of low-density lipoprotein cholesterol (LDL-C) levels (bad cholesterol) […]

Tigenix’ heart attack stem cell therapy trial delivers positive results

European cell therapy company TiGenix has announced positive top-line results for its cardiac stem cell trial evaulating its heart attack stem cell therapy AlloCSC-01 in patients facing the risk of getting heart failure after a coronary attack.

Tigenix’ heart attack stem cell therapy trial delivers positive results

TiGenix has announced that its cardiac stem cell study assessing its heart attack stem cell therapy with AlloCSC-01 was successful in patients having the risk of heart failure following a coronary attack. Tigenix Heart Attack Stem Cell Therapy with AlloCSC-01 The Belgium biopharma stated that its Phase I/II study of donor-derived expanded cardiac stem cells (AlloCSC) […]

Servier, Pfizer given FDA green signal for lymphoblastic leukemia drug

The UCART19 lymphoblastic leukemia drug jointly developed by Servier and Pfizer has been given the FDA clearance for its clinical development for lymphoblastic leukemia treatment.

Servier, Pfizer given FDA green signal for lymphoblastic leukemia drug

The US Food and Drug Administration (FDA) has given the green signal to Servier and Pfizer to carry out the clinical development of their UCART19 lymphoblastic leukemia drug for relapsed/refractory acute lymphoblastic leukemia treatment. In this regard, the FDA granted the pharmas with the Investigational New Drug (IND) clearance for the allogeneic, gene-edited cellular therapy […]

Secrets about Hair Care Tips for Summer Revealed

In this post, we will talk about how to get the best hair care in summer, we will reveal the best hair care tips for summer along with home remedies for hair care.

Secrets about Hair Care Tips for Summer Revealed

We usually take extra care of our skin in summer season compared to other seasons and we neglect to take care of our hair in summer. But hair care in summer also needs to be given utmost importance. This is because we use AC’s and coolers in summer to find relief from summer heat. This […]

Actelion’s Ledaga Chlormethine Gel for CTCL MF treatment gets EC approval

As per the Actelion recent news, the pharma’s Ledaga Chlormethine Gel 160 micrograms/g has been approved by the European Commission (EC) for CTCL MF treatment.

Actelion’s Ledaga Chlormethine Gel for CTCL MF treatment gets EC approval

Actelion recent news : The European Commission (EC) has approved Actelion Pharmaceuticals’ marketing authorization for its Ledaga Chlormethine Gel 160 micrograms/g for cutaneous T-cell lymphoma mycosis fungoides-type treatment, shortened as CTCL MF treatment. Ledaga Chlormethine Gel Details Approval of the topical, daily once and colorless gel by the EC comes in the wake of the […]

1 2 3 7